Follow The Filings

ABSI Absci

Absci earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ABSI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ABSI insider trades
  • $933K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mary T Szela Director
    Buy
    $149K 12,900 shares at $11.54 +154% to stake
    Traded Jun 30 Filed Jul 6
  2. Menelas N Pangalos Director
    Buy
    $201K 37,453 shares at $5.36 +19% to stake
    Traded May 13 Filed May 13
  3. Andreas Busch Chief Innovation Officer
    Buy
    $229K 100,000 shares at $2.29 +31% to stake
    Traded Mar 12 Filed Mar 16
  4. Menelas N Pangalos Director
    Buy
    $206K 75,095 shares at $2.74 +66% to stake
    Traded Feb 27 Filed Mar 3
  5. Frans Van Houten Director
    Buy
    $149K 40,000 shares at $3.72 +172% to stake
    Traded Dec 5, 2025 Filed Dec 9, 2025

Also filed in the last 12 months, not counted as buying or selling: 18 share withholdings for taxes, 12 stock grants, 2 sales to cover taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 2.02,8.01,9.01
10-Q
8-K 8.01
424B5
8-K 1.01,8.01,9.01
8-K 5.07
8-K 2.02,8.01,9.01
10-Q
DEF 14A
DEFA14A
SCHEDULE 13D/A —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
8-K 2.02,8.01,9.01
10-K
8-K 1.01,5.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.